165 related articles for article (PubMed ID: 15921860)
1. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
Hama E; Saido TC
Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.
Saito T; Iwata N; Tsubuki S; Takaki Y; Takano J; Huang SM; Suemoto T; Higuchi M; Saido TC
Nat Med; 2005 Apr; 11(4):434-9. PubMed ID: 15778722
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin and Alzheimer's disease.
Burgos-Ramos E; Hervás-Aguilar A; Aguado-Llera D; Puebla-Jiménez L; Hernández-Pinto AM; Barrios V; Arilla-Ferreiro E
Mol Cell Endocrinol; 2008 May; 286(1-2):104-11. PubMed ID: 18359553
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of amyloid-beta peptide and Alzheimer's disease.
Iwata N; Higuchi M; Saido TC
Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
[TBL] [Abstract][Full Text] [Related]
5. Metabolic regulation of brain Abeta by neprilysin.
Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
[TBL] [Abstract][Full Text] [Related]
6. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.
Russo R; Borghi R; Markesbery W; Tabaton M; Piccini A
FEBS Lett; 2005 Nov; 579(27):6027-30. PubMed ID: 16226260
[TBL] [Abstract][Full Text] [Related]
7. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
[TBL] [Abstract][Full Text] [Related]
9. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
Tanzi RE; Moir RD; Wagner SL
Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642
[TBL] [Abstract][Full Text] [Related]
10. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
Iwata N; Takaki Y; Fukami S; Tsubuki S; Saido TC
J Neurosci Res; 2002 Nov; 70(3):493-500. PubMed ID: 12391610
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
12. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition.
Iwata N; Tsubuki S; Takaki Y; Watanabe K; Sekiguchi M; Hosoki E; Kawashima-Morishima M; Lee HJ; Hama E; Sekine-Aizawa Y; Saido TC
Nat Med; 2000 Feb; 6(2):143-50. PubMed ID: 10655101
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy.
Saido TC; Iwata N
Neurosci Res; 2006 Apr; 54(4):235-53. PubMed ID: 16457902
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells.
Chen KL; Wang SS; Yang YY; Yuan RY; Chen RM; Hu CJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):57-61. PubMed ID: 19007750
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory.
Zou LB; Mouri A; Iwata N; Saido TC; Wang D; Wang MW; Mizoguchi H; Noda Y; Nabeshima T
J Pharmacol Exp Ther; 2006 Apr; 317(1):334-40. PubMed ID: 16382024
[TBL] [Abstract][Full Text] [Related]
17. Neprilysin activity and expression are controlled by nicastrin.
Pardossi-Piquard R; Dunys J; Yu G; St George-Hyslop P; Alves da Costa C; Checler F
J Neurochem; 2006 May; 97(4):1052-6. PubMed ID: 16606360
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'?
Moro ML; Collins MJ; Cappellini E
Biochem Soc Trans; 2010 Apr; 38(2):539-44. PubMed ID: 20298218
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
[TBL] [Abstract][Full Text] [Related]
20. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
Manzano-León N; Mas-Oliva J
Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
